Beta-Lactam Drugs Market - Global Outlook and Forecast 2021-2027

Beta-Lactam Drugs Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687426 | No. of Pages: 91 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021
This report contains market size and forecasts of Beta-Lactam Drugs in Global, including the following market information:
Global Beta-Lactam Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Beta-Lactam Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Beta-Lactam Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Beta-Lactam Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Beta-Lactam Drugs Market Segment Percentages, By Type, 2020 (%)
Penicillin
Cephalosporins
Carbapenem
Monobacteria

China Beta-Lactam Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Beta-Lactam Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Beta-Lactam Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Beta-Lactam Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Beta-Lactam Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Beta-Lactam Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
GlaxoSmithKline plc
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Eli Lilly and Company
Shionogi & Co., Ltd.
1 Introduction to Research & Analysis Reports
    1.1 Beta-Lactam Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Beta-Lactam Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Beta-Lactam Drugs Overall Market Size
    2.1 Global Beta-Lactam Drugs Market Size: 2021 VS 2027
    2.2 Global Beta-Lactam Drugs Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Beta-Lactam Drugs Players in Global Market
    3.2 Top Global Beta-Lactam Drugs Companies Ranked by Revenue
    3.3 Global Beta-Lactam Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Beta-Lactam Drugs Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Beta-Lactam Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Beta-Lactam Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Beta-Lactam Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Beta-Lactam Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Beta-Lactam Drugs Market Size Markets, 2021 & 2027
        4.1.2 Penicillin
        4.1.3 Cephalosporins
        4.1.4 Carbapenem
        4.1.5 Monobacteria
    4.2 By Type - Global Beta-Lactam Drugs Revenue & Forecasts
        4.2.1 By Type - Global Beta-Lactam Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Beta-Lactam Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Beta-Lactam Drugs Market Size, 2021 & 2027
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Beta-Lactam Drugs Revenue & Forecasts
        5.2.1 By Application - Global Beta-Lactam Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Beta-Lactam Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Beta-Lactam Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Beta-Lactam Drugs Revenue & Forecasts
        6.2.1 By Region - Global Beta-Lactam Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Beta-Lactam Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Beta-Lactam Drugs Revenue, 2016-2027
        6.3.2 US Beta-Lactam Drugs Market Size, 2016-2027
        6.3.3 Canada Beta-Lactam Drugs Market Size, 2016-2027
        6.3.4 Mexico Beta-Lactam Drugs Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Beta-Lactam Drugs Revenue, 2016-2027
        6.4.2 Germany Beta-Lactam Drugs Market Size, 2016-2027
        6.4.3 France Beta-Lactam Drugs Market Size, 2016-2027
        6.4.4 U.K. Beta-Lactam Drugs Market Size, 2016-2027
        6.4.5 Italy Beta-Lactam Drugs Market Size, 2016-2027
        6.4.6 Russia Beta-Lactam Drugs Market Size, 2016-2027
        6.4.7 Nordic Countries Beta-Lactam Drugs Market Size, 2016-2027
        6.4.8 Benelux Beta-Lactam Drugs Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Beta-Lactam Drugs Revenue, 2016-2027
        6.5.2 China Beta-Lactam Drugs Market Size, 2016-2027
        6.5.3 Japan Beta-Lactam Drugs Market Size, 2016-2027
        6.5.4 South Korea Beta-Lactam Drugs Market Size, 2016-2027
        6.5.5 Southeast Asia Beta-Lactam Drugs Market Size, 2016-2027
        6.5.6 India Beta-Lactam Drugs Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Beta-Lactam Drugs Revenue, 2016-2027
        6.6.2 Brazil Beta-Lactam Drugs Market Size, 2016-2027
        6.6.3 Argentina Beta-Lactam Drugs Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Beta-Lactam Drugs Revenue, 2016-2027
        6.7.2 Turkey Beta-Lactam Drugs Market Size, 2016-2027
        6.7.3 Israel Beta-Lactam Drugs Market Size, 2016-2027
        6.7.4 Saudi Arabia Beta-Lactam Drugs Market Size, 2016-2027
        6.7.5 UAE Beta-Lactam Drugs Market Size, 2016-2027
7 Players Profiles
    7.1 GlaxoSmithKline plc
        7.1.1 GlaxoSmithKline plc Corporate Summary
        7.1.2 GlaxoSmithKline plc Business Overview
        7.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Major Product Offerings
        7.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Revenue in Global (2016-2021)
        7.1.5 GlaxoSmithKline plc Key News
    7.2 Pfizer, Inc.
        7.2.1 Pfizer, Inc. Corporate Summary
        7.2.2 Pfizer, Inc. Business Overview
        7.2.3 Pfizer, Inc. Beta-Lactam Drugs Major Product Offerings
        7.2.4 Pfizer, Inc. Beta-Lactam Drugs Revenue in Global (2016-2021)
        7.2.5 Pfizer, Inc. Key News
    7.3 AstraZeneca plc
        7.3.1 AstraZeneca plc Corporate Summary
        7.3.2 AstraZeneca plc Business Overview
        7.3.3 AstraZeneca plc Beta-Lactam Drugs Major Product Offerings
        7.3.4 AstraZeneca plc Beta-Lactam Drugs Revenue in Global (2016-2021)
        7.3.5 AstraZeneca plc Key News
    7.4 Merck & Co., Inc.
        7.4.1 Merck & Co., Inc. Corporate Summary
        7.4.2 Merck & Co., Inc. Business Overview
        7.4.3 Merck & Co., Inc. Beta-Lactam Drugs Major Product Offerings
        7.4.4 Merck & Co., Inc. Beta-Lactam Drugs Revenue in Global (2016-2021)
        7.4.5 Merck & Co., Inc. Key News
    7.5 Eli Lilly and Company
        7.5.1 Eli Lilly and Company Corporate Summary
        7.5.2 Eli Lilly and Company Business Overview
        7.5.3 Eli Lilly and Company Beta-Lactam Drugs Major Product Offerings
        7.5.4 Eli Lilly and Company Beta-Lactam Drugs Revenue in Global (2016-2021)
        7.5.5 Eli Lilly and Company Key News
    7.6 Shionogi & Co., Ltd.
        7.6.1 Shionogi & Co., Ltd. Corporate Summary
        7.6.2 Shionogi & Co., Ltd. Business Overview
        7.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Major Product Offerings
        7.6.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue in Global (2016-2021)
        7.6.5 Shionogi & Co., Ltd. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com